Wave Life Sciences, Inc.
WVE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001631574
In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
Q3 2025 vs. Q2 2025
How the institutions holding Wave Life Sciences, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 177 | 2 | 189 | +14 |
| Shares | 138.9M | 113.8K | 143.7M | +4.85M (+3.5%) |
| Value | $903.1M | $739.8K | $1.05B | +$149.2M (+16.5%) |
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (32)
Institutions that held Wave Life Sciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (18)
Institutions that held Wave Life Sciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Voloridge Investment Management, LLC | 683,193 | $4.44M |
| Woodline Partners LP | 452,060 | $2.94M |
| Principal Financial Group Inc | 302,276 | $1.96M |
| UBS Asset Management Americas Inc | 295,061 | $1.92M |
| D. E. Shaw & Co., Inc. | 271,474 | $1.76M |
| Compass Rose Asset Management, LP | 100,000 | $650.0K |
| Superstring Capital Management LP | 70,242 | $456.6K |
| Verition Fund Management LLC | 52,728 | $342.7K |
| Birchview Capital, LP | 40,300 | $261.9K |
| Susquehanna Fundamental Investments, LLC | 36,089 | $234.6K |
| Nebula Research & Development LLC | 34,342 | $223.2K |
| Citadel Advisors LLC | 32,405 | $210.6K |
| Algert Global LLC | 26,420 | $171.7K |
| Nomura Holdings Inc | 14,829 | $96.4K |
| STRS Ohio | 8,000 | $52.0K |
| IFP Advisors, Inc | 0 | $5.71K |
| Riggs Asset Managment Co. Inc. | 198 | $1.29K |
| Twin Peaks Wealth Advisors, LLC | 4 | $34 |
Not filed for Q3 2025 yet (2)
Institutions that held Wave Life Sciences, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Norges Bank | 100,000 | $650.0K |
| CIBC World Markets Corp | 13,811 | $89.8K |